Agios Pharma (AGIO) PT Maintained at Cantor Fitzgerald
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts AGIO Hot Sheet
Price: $30.97 +2.52%
Rating Summary:
17 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Rating Summary:
17 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Join SI Premium – FREE
Cantor Fitzgerald analyst Eric Schmidt maintained the price target on Agios Pharma (NASDAQ: AGIO) while maintaining a Overweight rating.
You May Also Be Interested In
- JD.com, Inc (JD) PT Lowered to $33 at US Tiger Securities
- Neo Performance Materials Inc. (NEO:CN) (NOPMF) PT Lowered to Cdn$50 at BMO Capital
- Citi (C) PT Lowered to $148; TD Cowen: 'Today's weakness an opportunity'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
